 |
 |
d as a marker to see ifthe strategy would work, future effort will use neurons transgenic for more important traits4or example, human proteins to make the cells immunologically acceptable to Parkinson~s patients, assuring greater success and avoiding costly immunosuppressive drugs. According to Steven Stice, chief scientific ofil- cer for Advanced Cell Technology, uThe ability to com- bine cloning with transgenics really enhances our capacity to produce genetically modified cells, organs, and animals for biomedical applications.~ Indeed, his group is applying the technology in other ways, includ- ing creating BSE-resistan cattle and growing specif- ic cells a~hd tissues from embryonic stem cells. d as a marker to see ifthe strategy would work, future effort will use neurons transgenic for more important traits4or example, human proteins to make the cells immunologically acceptable to Parkinson~s patients, assuring greater success and avoiding costly immunosuppressive drugs. According to Steven Stice, chief scientific ofil- cer for Advanced Cell Technology, uThe ability to com- bine cloning with transgenics really enhances our capacity to produce genetically modified cells, organs, and animals for biomedical applications.~ Indeed, his group is applying the technology in other ways, includ- ing creating BSE-resistan cattle and growing specif- ic cells a~hd tissues from embryonic stem cells. d as a marker to see ifthe strategy would work, future effort will use neurons transgenic for more important traits4or example, human proteins to make the cells immunologically acceptable to Parkinson~s patients, assuring greater success and avoiding costly immunosuppressive drugs. According to Steven Stice, chief scientific ofil- cer for Advanced Cell Technology, uThe ability to com- bine cloning with transgenics really enhances our capacity to produce genetically modified cells, organs, and animals for biomedical applications.~ Indeed, his group is applying the technology in other ways, includ- ing creating BSE-resistan cattle and growing specif- ic cells a~hd tissues from embryonic stem cells. d as a marker to see ifthe strategy would work, future effort will use neurons transgenic for more important traits4or example, human proteins to make the cells immunologically acceptable to Parkinson~s patients, assuring greater success and avoiding costly immunosuppressive drugs. According to Steven Stice, chief scientific ofil- cer for Advanced Cell Technology, uThe ability to com- bine cloning with transgenics really enhances our capacity to produce genetically modified cells, organs, and animals for biomedical applications.~ Indeed, his group is applying the technology in other ways, includ- ing creating BSE-resistan cattle and growing specif- ic cells a~hd tissues from embryonic stem cells.